EMEA (Europe, Middle East and Africa) Plasma-derived Factor VIII Market Report 2018

March 2018 | 106 pages | ID: E320DF58099EN
QYResearch

Abstracts

In this report, the EMEA Plasma-derived Factor VIII market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Plasma-derived Factor VIII for these regions, from 2013 to 2025 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Plasma-derived Factor VIII market competition by top manufacturers/players, with Plasma-derived Factor VIII sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Shire (Baxter)
• Octapharma
• CSL
• Grifols
• Greencross
• Kedrion
• BPL
• Hualan Bio
• RAAS

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• 200IU
• 250IU

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospital
• Pharmacy

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Plasma-derived Factor VIII Market Report 2018

1 PLASMA-DERIVED FACTOR VIII OVERVIEW

1.1 Product Overview and Scope of Plasma-derived Factor VIII
1.2 Classification of Plasma-derived Factor VIII
  1.2.1 EMEA Plasma-derived Factor VIII Market Size (Sales) Comparison by Type (2013-2025)
  1.2.2 EMEA Plasma-derived Factor VIII Market Size (Sales) Market Share by Type (Product Category) in 2017
  1.2.3 200IU
  1.2.4 250IU
1.3 EMEA Plasma-derived Factor VIII Market by Application/End Users
  1.3.1 EMEA Plasma-derived Factor VIII Sales (Volume) and Market Share Comparison by Application (2013-2025)
  1.3.2 Hospital
  1.3.3 Pharmacy
1.4 EMEA Plasma-derived Factor VIII Market by Region
  1.4.1 EMEA Plasma-derived Factor VIII Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 Europe Status and Prospect (2013-2025)
  1.4.3 Middle East Status and Prospect (2013-2025)
  1.4.4 Africa Status and Prospect (2013-2025)
1.5 EMEA Market Size (Value and Volume) of Plasma-derived Factor VIII (2013-2025)
  1.5.1 EMEA Plasma-derived Factor VIII Sales and Growth Rate (2013-2025)
  1.5.2 EMEA Plasma-derived Factor VIII Revenue and Growth Rate (2013-2025)

2 EMEA PLASMA-DERIVED FACTOR VIII COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Plasma-derived Factor VIII Market Competition by Players/Manufacturers
  2.1.1 EMEA Plasma-derived Factor VIII Sales Volume and Market Share of Major Players (2013-2018)
  2.1.2 EMEA Plasma-derived Factor VIII Revenue and Share by Players (2013-2018)
  2.1.3 EMEA Plasma-derived Factor VIII Sale Price by Players (2013-2018)
2.2 EMEA Plasma-derived Factor VIII (Volume and Value) by Type/Product Category
  2.2.1 EMEA Plasma-derived Factor VIII Sales and Market Share by Type (2013-2018)
  2.2.2 EMEA Plasma-derived Factor VIII Revenue and Market Share by Type (2013-2018)
  2.2.3 EMEA Plasma-derived Factor VIII Sale Price by Type (2013-2018)
2.3 EMEA Plasma-derived Factor VIII (Volume) by Application
2.4 EMEA Plasma-derived Factor VIII (Volume and Value) by Region
  2.4.1 EMEA Plasma-derived Factor VIII Sales and Market Share by Region (2013-2018)
  2.4.2 EMEA Plasma-derived Factor VIII Revenue and Market Share by Region (2013-2018)
  2.4.3 EMEA Plasma-derived Factor VIII Sales Price by Region (2013-2018)

3 EUROPE PLASMA-DERIVED FACTOR VIII (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Plasma-derived Factor VIII Sales and Value (2013-2018)
  3.1.1 Europe Plasma-derived Factor VIII Sales Volume and Growth Rate (2013-2018)
  3.1.2 Europe Plasma-derived Factor VIII Revenue and Growth Rate (2013-2018)
3.2 Europe Plasma-derived Factor VIII Sales and Market Share by Type
3.3 Europe Plasma-derived Factor VIII Sales and Market Share by Application
3.4 Europe Plasma-derived Factor VIII Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Plasma-derived Factor VIII Sales Volume by Countries (2013-2018)
  3.4.2 Europe Plasma-derived Factor VIII Revenue by Countries (2013-2018)
  3.4.3 Germany Plasma-derived Factor VIII Sales and Growth Rate (2013-2018)
  3.4.4 France Plasma-derived Factor VIII Sales and Growth Rate (2013-2018)
  3.4.5 UK Plasma-derived Factor VIII Sales and Growth Rate (2013-2018)
  3.4.6 Russia Plasma-derived Factor VIII Sales and Growth Rate (2013-2018)
  3.4.7 Italy Plasma-derived Factor VIII Sales and Growth Rate (2013-2018)
  3.4.8 Benelux Plasma-derived Factor VIII Sales and Growth Rate (2013-2018)

4 MIDDLE EAST PLASMA-DERIVED FACTOR VIII (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Plasma-derived Factor VIII Sales and Value (2013-2018)
  4.1.1 Middle East Plasma-derived Factor VIII Sales Volume and Growth Rate (2013-2018)
  4.1.2 Middle East Plasma-derived Factor VIII Revenue and Growth Rate (2013-2018)
4.2 Middle East Plasma-derived Factor VIII Sales and Market Share by Type
4.3 Middle East Plasma-derived Factor VIII Sales and Market Share by Application
4.4 Middle East Plasma-derived Factor VIII Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Plasma-derived Factor VIII Sales Volume by Countries (2013-2018)
  4.4.2 Middle East Plasma-derived Factor VIII Revenue by Countries (2013-2018)
  4.4.3 Saudi Arabia Plasma-derived Factor VIII Sales and Growth Rate (2013-2018)
  4.4.4 Israel Plasma-derived Factor VIII Sales and Growth Rate (2013-2018)
  4.4.5 UAE Plasma-derived Factor VIII Sales and Growth Rate (2013-2018)
  4.4.6 Iran Plasma-derived Factor VIII Sales and Growth Rate (2013-2018)

5 AFRICA PLASMA-DERIVED FACTOR VIII (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Plasma-derived Factor VIII Sales and Value (2013-2018)
  5.1.1 Africa Plasma-derived Factor VIII Sales Volume and Growth Rate (2013-2018)
  5.1.2 Africa Plasma-derived Factor VIII Revenue and Growth Rate (2013-2018)
5.2 Africa Plasma-derived Factor VIII Sales and Market Share by Type
5.3 Africa Plasma-derived Factor VIII Sales and Market Share by Application
5.4 Africa Plasma-derived Factor VIII Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Plasma-derived Factor VIII Sales Volume by Countries (2013-2018)
  5.4.2 Africa Plasma-derived Factor VIII Revenue by Countries (2013-2018)
  5.4.3 South Africa Plasma-derived Factor VIII Sales and Growth Rate (2013-2018)
  5.4.4 Nigeria Plasma-derived Factor VIII Sales and Growth Rate (2013-2018)
  5.4.5 Egypt Plasma-derived Factor VIII Sales and Growth Rate (2013-2018)
  5.4.6 Algeria Plasma-derived Factor VIII Sales and Growth Rate (2013-2018)

6 EMEA PLASMA-DERIVED FACTOR VIII MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Shire (Baxter)
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Plasma-derived Factor VIII Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Shire (Baxter) Plasma-derived Factor VIII Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Octapharma
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Plasma-derived Factor VIII Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Octapharma Plasma-derived Factor VIII Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 CSL
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Plasma-derived Factor VIII Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 CSL Plasma-derived Factor VIII Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Grifols
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Plasma-derived Factor VIII Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Grifols Plasma-derived Factor VIII Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Greencross
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Plasma-derived Factor VIII Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Greencross Plasma-derived Factor VIII Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Kedrion
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Plasma-derived Factor VIII Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Kedrion Plasma-derived Factor VIII Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 BPL
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Plasma-derived Factor VIII Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 BPL Plasma-derived Factor VIII Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Hualan Bio
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Plasma-derived Factor VIII Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Hualan Bio Plasma-derived Factor VIII Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 RAAS
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Plasma-derived Factor VIII Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 RAAS Plasma-derived Factor VIII Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview

7 PLASMA-DERIVED FACTOR VIII MANUFACTURING COST ANALYSIS

7.1 Plasma-derived Factor VIII Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Plasma-derived Factor VIII

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Plasma-derived Factor VIII Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Plasma-derived Factor VIII Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA PLASMA-DERIVED FACTOR VIII MARKET FORECAST (2018-2025)

11.1 EMEA Plasma-derived Factor VIII Sales, Revenue and Price Forecast (2018-2025)
  11.1.1 EMEA Plasma-derived Factor VIII Sales and Growth Rate Forecast (2018-2025)
  11.1.2 EMEA Plasma-derived Factor VIII Revenue and Growth Rate Forecast (2018-2025)
  11.1.3 EMEA Plasma-derived Factor VIII Price and Trend Forecast (2018-2025)
11.2 EMEA Plasma-derived Factor VIII Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.3 Europe Plasma-derived Factor VIII Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.4 Middle Eastt Plasma-derived Factor VIII Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.5 Africa Plasma-derived Factor VIII Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.6 EMEA Plasma-derived Factor VIII Sales Forecast by Type (2018-2025)
11.7 EMEA Plasma-derived Factor VIII Sales Forecast by Application (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Plasma-derived Factor VIII
Figure EMEA Plasma-derived Factor VIII Sales Volume (K Units) by Type (2013-2025)
Figure EMEA Plasma-derived Factor VIII Sales Volume Market Share by Type (Product Category) in 2017
Figure 200IU Product Picture
Figure 250IU Product Picture
Figure EMEA Plasma-derived Factor VIII Sales Volume (K Units) by Application (2013-2025)
Figure EMEA Sales Market Share of Plasma-derived Factor VIII by Application in 2017
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Pharmacy Examples
Table Key Downstream Customer in Pharmacy
Figure EMEA Plasma-derived Factor VIII Market Size (Million USD) by Region (2013-2025)
Figure Europe Plasma-derived Factor VIII Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Plasma-derived Factor VIII Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Plasma-derived Factor VIII Revenue (Million USD) and Growth Rate (2013-2025)
Figure Middle East Plasma-derived Factor VIII Revenue (Million USD) Status and Forecast by Countries
Figure Africa Plasma-derived Factor VIII Revenue (Million USD) and Growth Rate (2013-2025)
Figure Africa Plasma-derived Factor VIII Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Plasma-derived Factor VIII Sales Volume and Growth Rate (2013-2025)
Figure EMEA Plasma-derived Factor VIII Revenue (Million USD) and Growth Rate (2013-2025)
Figure EMEA Plasma-derived Factor VIII Market Major Players Product Sales Volume (K Units) (2013-2018)
Table EMEA Plasma-derived Factor VIII Sales Volume (K Units) of Major Players (2013-2018)
Table EMEA Plasma-derived Factor VIII Sales Share by Players (2013-2018)
Figure 2017 Plasma-derived Factor VIII Sales Share by Players
Figure 2017 Plasma-derived Factor VIII Sales Share by Players
Figure EMEA Plasma-derived Factor VIII Market Major Players Product Revenue (Million USD) (2013-2018)
Table EMEA Plasma-derived Factor VIII Revenue (Million USD) by Players (2013-2018)
Table EMEA Plasma-derived Factor VIII Revenue Share by Players (2013-2018)
Table 2017 EMEA Plasma-derived Factor VIII Revenue Share by Players
Table 2017 EMEA Plasma-derived Factor VIII Revenue Share by Players
Table EMEA Plasma-derived Factor VIII Sale Price (USD/Unit) by Players (2013-2018)
Table EMEA Plasma-derived Factor VIII Sales (K Units) and Market Share by Type (2013-2018)
Table EMEA Plasma-derived Factor VIII Sales Share by Type (2013-2018)
Figure Sales Market Share of Plasma-derived Factor VIII by Type (2013-2018)
Figure EMEA Plasma-derived Factor VIII Sales Market Share by Type (2013-2018)
Table EMEA Plasma-derived Factor VIII Revenue (Million USD) and Market Share by Type (2013-2018)
Table EMEA Plasma-derived Factor VIII Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Plasma-derived Factor VIII by Type in 2017
Table EMEA Plasma-derived Factor VIII Sale Price (USD/Unit) by Type (2013-2018)
Table EMEA Plasma-derived Factor VIII Sales (K Units) and Market Share by Application (2013-2018)
Table EMEA Plasma-derived Factor VIII Sales Share by Application (2013-2018)
Figure Sales Market Share of Plasma-derived Factor VIII by Application (2013-2018)
Figure EMEA Plasma-derived Factor VIII Sales Market Share by Application in 2017
Table EMEA Plasma-derived Factor VIII Sales (K Units) and Market Share by Region (2013-2018)
Table EMEA Plasma-derived Factor VIII Sales Share by Region (2013-2018)
Figure Sales Market Share of Plasma-derived Factor VIII by Region (2013-2018)
Figure EMEA Plasma-derived Factor VIII Sales Market Share in 2017
Table EMEA Plasma-derived Factor VIII Revenue (Million USD) and Market Share by Region (2013-2018)
Table EMEA Plasma-derived Factor VIII Revenue Share by Region (2013-2018)
Figure Revenue Market Share of Plasma-derived Factor VIII by Region (2013-2018)
Figure EMEA Plasma-derived Factor VIII Revenue Market Share Regions in 2017
Table EMEA Plasma-derived Factor VIII Sales Price (USD/Unit) by Region (2013-2018)
Figure Europe Plasma-derived Factor VIII Sales (K Units) and Growth Rate (2013-2018)
Figure Europe Plasma-derived Factor VIII Revenue and Growth Rate (2013-2018)
Table Europe Plasma-derived Factor VIII Sales (K Units) by Type (2013-2018)
Table Europe Plasma-derived Factor VIII Market Share by Type (2013-2018)
Figure Europe Plasma-derived Factor VIII Market Share by Type in 2017
Table Europe Plasma-derived Factor VIII Sales (K Units) by Application (2013-2018)
Table Europe Plasma-derived Factor VIII Market Share by Application (2013-2018)
Figure Europe Plasma-derived Factor VIII Market Share by Application in 2017
Table Europe Plasma-derived Factor VIII Sales (K Units) by Countries (2013-2018)
Table Europe Plasma-derived Factor VIII Sales Market Share by Countries (2013-2018)
Figure Europe Plasma-derived Factor VIII Sales Market Share by Countries (2013-2018)
Figure Europe Plasma-derived Factor VIII Sales Market Share by Countries in 2017
Table Europe Plasma-derived Factor VIII Revenue (Million USD) by Countries (2013-2018)
Table Europe Plasma-derived Factor VIII Revenue Market Share by Countries (2013-2018)
Figure Europe Plasma-derived Factor VIII Revenue Market Share by Countries (2013-2018)
Figure Europe Plasma-derived Factor VIII Revenue Market Share by Countries in 2017
Figure Germany Plasma-derived Factor VIII Sales (K Units) and Growth Rate (2013-2018)
Figure France Plasma-derived Factor VIII Sales (K Units) and Growth Rate (2013-2018)
Figure UK Plasma-derived Factor VIII Sales (K Units) and Growth Rate (2013-2018)
Figure Russia Plasma-derived Factor VIII Sales (K Units) and Growth Rate (2013-2018)
Figure Italy Plasma-derived Factor VIII Sales (K Units) and Growth Rate (2013-2018)
Figure Benelux Plasma-derived Factor VIII Sales (K Units) and Growth Rate (2013-2018)
Figure Middle East Plasma-derived Factor VIII Sales (K Units) and Growth Rate (2013-2018)
Figure Middle East Plasma-derived Factor VIII Revenue (Million USD) and Growth Rate (2013-2018)
Table Middle East Plasma-derived Factor VIII Sales (K Units) by Type (2013-2018)
Table Middle East Plasma-derived Factor VIII Market Share by Type (2013-2018)
Figure Middle East Plasma-derived Factor VIII Market Share by Type (2013-2018)
Table Middle East Plasma-derived Factor VIII Sales (K Units) by Applications (2013-2018)
Table Middle East Plasma-derived Factor VIII Market Share by Applications (2013-2018)
Figure Middle East Plasma-derived Factor VIII Sales Market Share by Application in 2017
Table Middle East Plasma-derived Factor VIII Sales Volume (K Units) by Countries (2013-2018)
Table Middle East Plasma-derived Factor VIII Sales Volume Market Share by Countries (2013-2018)
Figure Middle East Plasma-derived Factor VIII Sales Volume Market Share by Countries in 2017
Table Middle East Plasma-derived Factor VIII Revenue (Million USD) by Countries (2013-2018)
Table Middle East Plasma-derived Factor VIII Revenue Market Share by Countries (2013-2018)
Figure Middle East Plasma-derived Factor VIII Revenue Market Share by Countries (2013-2018)
Figure Middle East Plasma-derived Factor VIII Revenue Market Share by Countries in 2017
Figure Saudi Arabia Plasma-derived Factor VIII Sales (K Units) and Growth Rate (2013-2018)
Figure Israel Plasma-derived Factor VIII Sales (K Units) and Growth Rate (2013-2018)
Figure UAE Plasma-derived Factor VIII Sales (K Units) and Growth Rate (2013-2018)
Figure Iran Plasma-derived Factor VIII Sales (K Units) and Growth Rate (2013-2018)
Figure Africa Plasma-derived Factor VIII Sales (K Units) and Growth Rate (2013-2018)
Figure Africa Plasma-derived Factor VIII Revenue (Million USD) and Growth Rate (2013-2018)
Table Africa Plasma-derived Factor VIII Sales (K Units) by Type (2013-2018)
Table Africa Plasma-derived Factor VIII Sales Market Share by Type (2013-2018)
Figure Africa Plasma-derived Factor VIII Sales Market Share by Type (2013-2018)
Figure Africa Plasma-derived Factor VIII Sales Market Share by Type in 2017
Table Africa Plasma-derived Factor VIII Sales (K Units) by Application (2013-2018)
Table Africa Plasma-derived Factor VIII Sales Market Share by Application (2013-2018)
Figure Africa Plasma-derived Factor VIII Sales Market Share by Application (2013-2018)
Table Africa Plasma-derived Factor VIII Sales Volume (K Units) by Countries (2013-2018)
Table Africa Plasma-derived Factor VIII Sales Market Share by Countries (2013-2018)
Figure Africa Plasma-derived Factor VIII Sales Market Share by Countries (2013-2018)
Figure Africa Plasma-derived Factor VIII Sales Market Share by Countries in 2017
Table Africa Plasma-derived Factor VIII Revenue (Million USD) by Countries (2013-2018)
Table Africa Plasma-derived Factor VIII Revenue Market Share by Countries (2013-2018)
Figure Africa Plasma-derived Factor VIII Revenue Market Share by Countries (2013-2018)
Figure Africa Plasma-derived Factor VIII Revenue Market Share by Countries in 2017
Figure South Africa Plasma-derived Factor VIII Sales (K Units) and Growth Rate (2013-2018)
Figure Nigeria Plasma-derived Factor VIII Sales (K Units) and Growth Rate (2013-2018)
Figure Egypt Plasma-derived Factor VIII Sales (K Units) and Growth Rate (2013-2018)
Figure Algeria Plasma-derived Factor VIII Sales (K Units) and Growth Rate (2013-2018)
Table Shire (Baxter) Plasma-derived Factor VIII Basic Information List
Table Shire (Baxter) Plasma-derived Factor VIII Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Shire (Baxter) Plasma-derived Factor VIII Sales (K Units) and Growth Rate (2013-2018)
Figure Shire (Baxter) Plasma-derived Factor VIII Sales Market Share in EMEA (2013-2018)
Figure Shire (Baxter) Plasma-derived Factor VIII Revenue Market Share in EMEA (2013-2018)
Table Octapharma Plasma-derived Factor VIII Basic Information List
Table Octapharma Plasma-derived Factor VIII Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Octapharma Plasma-derived Factor VIII Sales (K Units) and Growth Rate (2013-2018)
Figure Octapharma Plasma-derived Factor VIII Sales Market Share in EMEA (2013-2018)
Figure Octapharma Plasma-derived Factor VIII Revenue Market Share in EMEA (2013-2018)
Table CSL Plasma-derived Factor VIII Basic Information List
Table CSL Plasma-derived Factor VIII Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure CSL Plasma-derived Factor VIII Sales (K Units) and Growth Rate (2013-2018)
Figure CSL Plasma-derived Factor VIII Sales Market Share in EMEA (2013-2018)
Figure CSL Plasma-derived Factor VIII Revenue Market Share in EMEA (2013-2018)
Table Grifols Plasma-derived Factor VIII Basic Information List
Table Grifols Plasma-derived Factor VIII Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Grifols Plasma-derived Factor VIII Sales (K Units) and Growth Rate (2013-2018)
Figure Grifols Plasma-derived Factor VIII Sales Market Share in EMEA (2013-2018)
Figure Grifols Plasma-derived Factor VIII Revenue Market Share in EMEA (2013-2018)
Table Greencross Plasma-derived Factor VIII Basic Information List
Table Greencross Plasma-derived Factor VIII Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Greencross Plasma-derived Factor VIII Sales (K Units) and Growth Rate (2013-2018)
Figure Greencross Plasma-derived Factor VIII Sales Market Share in EMEA (2013-2018)
Figure Greencross Plasma-derived Factor VIII Revenue Market Share in EMEA (2013-2018)
Table Kedrion Plasma-derived Factor VIII Basic Information List
Table Kedrion Plasma-derived Factor VIII Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Kedrion Plasma-derived Factor VIII Sales (K Units) and Growth Rate (2013-2018)
Figure Kedrion Plasma-derived Factor VIII Sales Market Share in EMEA (2013-2018)
Figure Kedrion Plasma-derived Factor VIII Revenue Market Share in EMEA (2013-2018)
Table BPL Plasma-derived Factor VIII Basic Information List
Table BPL Plasma-derived Factor VIII Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure BPL Plasma-derived Factor VIII Sales (K Units) and Growth Rate (2013-2018)
Figure BPL Plasma-derived Factor VIII Sales Market Share in EMEA (2013-2018)
Figure BPL Plasma-derived Factor VIII Revenue Market Share in EMEA (2013-2018)
Table Hualan Bio Plasma-derived Factor VIII Basic Information List
Table Hualan Bio Plasma-derived Factor VIII Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Hualan Bio Plasma-derived Factor VIII Sales (K Units) and Growth Rate (2013-2018)
Figure Hualan Bio Plasma-derived Factor VIII Sales Market Share in EMEA (2013-2018)
Figure Hualan Bio Plasma-derived Factor VIII Revenue Market Share in EMEA (2013-2018)
Table RAAS Plasma-derived Factor VIII Basic Information List
Table RAAS Plasma-derived Factor VIII Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure RAAS Plasma-derived Factor VIII Sales (K Units) and Growth Rate (2013-2018)
Figure RAAS Plasma-derived Factor VIII Sales Market Share in EMEA (2013-2018)
Figure RAAS Plasma-derived Factor VIII Revenue Market Share in EMEA (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Plasma-derived Factor VIII
Figure Manufacturing Process Analysis of Plasma-derived Factor VIII
Figure Plasma-derived Factor VIII Industrial Chain Analysis
Table Raw Materials Sources of Plasma-derived Factor VIII Major Manufacturers in 2017
Table Major Buyers of Plasma-derived Factor VIII
Table Distributors/Traders List
Figure EMEA Plasma-derived Factor VIII Sales (K Units) and Growth Rate Forecast (2018-2025)
Figure EMEA Plasma-derived Factor VIII Revenue and Growth Rate Forecast (2018-2025)
Figure EMEA Plasma-derived Factor VIII Price (USD/Unit) and Trend Forecast (2018-2025)
Table EMEA Plasma-derived Factor VIII Sales (K Units) Forecast by Region (2018-2025)
Figure EMEA Plasma-derived Factor VIII Sales Market Share Forecast by Region (2018-2025)
Table EMEA Plasma-derived Factor VIII Revenue (Million USD) Forecast by Region (2018-2025)
Figure EMEA Plasma-derived Factor VIII Revenue Market Share Forecast by Region (2018-2025)
Table Europe Plasma-derived Factor VIII Sales (K Units) Forecast by Countries (2018-2025)
Figure Europe Plasma-derived Factor VIII Sales Market Share Forecast by Countries (2018-2025)
Table Europe Plasma-derived Factor VIII Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Europe Plasma-derived Factor VIII Revenue Market Share Forecast by Countries (2018-2025)
Table Middle East Plasma-derived Factor VIII Sales (K Units) Forecast by Countries (2018-2025)
Figure Middle East Plasma-derived Factor VIII Sales Market Share Forecast by Countries (2018-2025)
Table Middle East Plasma-derived Factor VIII Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Middle East Plasma-derived Factor VIII Revenue Market Share Forecast by Countries (2018-2025)
Table Africa Plasma-derived Factor VIII Sales (K Units) Forecast by Countries (2018-2025)
Figure Africa Plasma-derived Factor VIII Sales Market Share Forecast by Countries (2018-2025)
Table Africa Plasma-derived Factor VIII Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Africa Plasma-derived Factor VIII Revenue Market Share Forecast by Countries (2018-2025)
Table EMEA Plasma-derived Factor VIII Sales (K Units) Forecast by Type (2018-2025)
Figure EMEA Plasma-derived Factor VIII Sales Market Share Forecast by Type (2018-2025)
Table EMEA Plasma-derived Factor VIII Sales (K Units) Forecast by Application (2018-2025)
Figure EMEA Plasma-derived Factor VIII Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources